Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy
Aasha I. Hoogland, Anna Barata, Jennifer M. Logue, Anuhya Kommalapati, Kelly A. Hyland, Ashley M. Nelson, Sarah L. Eisel, Brent J. Small, Brian W. James, Shannon M. Christy, Hailey W. Bulls, Margaret Booth‐Jones, Reena Jayani, Michael D. Jain, Sepideh Mokhtari, Julio C. Chávez, Aleksandr Lazaryan, Bijal Shah, Frederick L. Locke, Heather Jim
Topics & Concepts
NeurocognitiveMedicineNeurotoxicityChimeric antigen receptorLymphomaInternal medicineOncologyRegimenCognitionPediatricsCancerPsychiatryToxicityImmunotherapyCAR-T cell therapy researchCancer-related cognitive impairment studiesGraphene and Nanomaterials Applications